… for diagnosis from 1980 that was used in this study has since been updated and diagnosis
is … associated with antibiotics regimens such as the development of C. difficile, each patient’s …

… article will review the updated evidence on the epidemiology, pathogenesis, clinical
manifestations, diagnosis, and treatment … studies and pragmatic clinical trials are needed to …

… In a systematic review of 5295 articles for possible treatments … Diagnosis of small intestinal
bacterial overgrowth in patients with … Testing and treating small intestinal bacterial overgrowth …

… in patients with SIBO, resulting in a higher risk of developing NAFLD. … Second, some of
the included studies used lactulose breath test to diagnose SIBO. Because lactulose breath …

… needed to develop validated symptom assessment tools and … Several studies have shown
that antibiotic therapy in patients … by the University Institutional Review Board, and informed …

… Although rifaximin is used worldwide for treatment of SIBO, 32 , … Each subtype and clinical
characteristics were shown in … to be a risk factor for development of SIBO, though that …

… These limitations have led to the development of breath tests, … to antibiotic therapy regarding
normalization of breath tests and … on the small intestinal bacterial overgrowth prevalence in …

… The clinical characteristics of the study and control groups … Shah et al21 performed a
systematic review and meta-… To date, no studies have been published concerning the treatment …

… These limitations have led to the development of breath tests, … and studied small intestinal
dysbiosis is small intestinal bacterial … with severity of the clinical manifestation. In the more …

… Rifaximin therapy is well tolerated and the results are … Patients affected with CF are at risk
of developing SIBO due to … the prevalence, risk factors and clinical manifestations of SIBO in a …